Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11160784 Treatment of brain metastases using organonitro compound combination therapy

Patent 11160784 was granted and assigned to EpicentRx on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jan Scicinski0

Bryan T. Oronsky0

Date of Patent

November 2, 2021

0

Patent Application Number

201906280

Date Filed

June 28, 2019

0

Patent Citations Received

US Patent 11925617 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof

0

US Patent 11576895 Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone

US Patent 11660286 Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products

0

US Patent 11701351 Treatment of gliomas using organonitro compound combination therapy

0

US Patent 11744859 Compositions and methods for parenteral administration of therapeutic agents

US Patent 11510901 Methods and compositions utilizing RRx-001 combination therapy for radioprotection

0

Patent abstract

The invention provides therapeutic methods and kits for treating brain metastases using a particular dosing regimen of the organonitro compound ABDNAZ, radiation therapy, and optionally an additional anti-cancer agent.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11160784 Treatment of brain metastases using organonitro compound combination therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool